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Retinoid X Receptors intersect the 
Molecular Clockwork in the 
Regulation of Liver Metabolism
Salvatore De Cosmo and Gianluigi Mazzoccoli*
Department of Medical Sciences, Division of Internal Medicine and Chronobiology Unit, IRCCS “Ospedale Casa Sollievo 
della Sofferenza”, San Giovanni Rotondo, Italy
Liver metabolic pathways are driven by the biological clock, and appropriate timing of 
24-h patterns of metabolic gene expression as well as anabolic/catabolic processes with 
wake-related activity/feeding and sleep-related resting/fasting cycles preserves hepatic 
healthiness. The interplay among the liver metabolic pathways and the molecular clock-
work is geared by the nuclear receptors, and ligand-dependent transcription factors that 
gauge the cellular nutritional status and redox balance, bind hormones and metabolites, 
and modulate the transcription of thousands target genes through their DNA-binding 
domain. Several nuclear receptors in the liver oscillate with circadian rhythmicity, and 
among these, the retinoid X receptors play a key role in metabolism regulation, intersect-
ing with the cogs of the molecular clockwork.
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inTRODUCTiOn
The regulation of lipid and glucose metabolism in the liver requires cell sensors capable of 
monitoring the concentration of nutrients and coordinating the enzyme cascades that regulate 
the synthesis and oxidation of metabolites. In this regard, the nuclear receptors are transcription 
factors that act as intracellular sensors, which are able to regulate lipid and glucose metabolism. 
Unlike extracellular receptors, which bind to protein ligands (e.g., growth factors and insulin) 
at the plasma membrane and activate cytoplasmic cascades, nuclear receptors interact directly 
with lipophilic ligands and regulate the expression of target genes (1). Members of the nuclear 
receptor superfamily function as ligand-dependent transcription factors that bind to promoters 
of specific DNA sequences. The nuclear receptors bind hormones, such as cortisol, melatonin, 
and 3,5,3′-triiodothyronine, and metabolites, such as lipids, oxysterols, heme, and bile acids, and 
sense redox balance and nutrient levels in the cell. The nuclear receptors have in common similar 
domain organizations, especially the DNA-binding domain (DBD) and the ligand-binding domain 
(LBD) that are crucial in amplifying hormone and metabolite signaling by specifically targeted 
genes. Binding of specific ligands to the precise receptor prompts ligand-induced conformational 
variations in the receptor, receptor translocation to the nucleus, receptor dimerization, interaction 
with target gene promoter elements, release/recruitment of coactivators or corepressors, chromatin 
remodeling, and finally interplay with the polymerase II complex to start transcription (2).
THe ReTinOiD X ReCePTORS (RXRs)
The RXR subtypes or isotypes α–γ (NR2B1–3) are encoded by RXRα–γ genes located on chro-
mosomes 9 (band q34.3), 6 (band 21.3), and 1 (band q22–q23), respectively, and are members 
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of the orphan nuclear receptor family since natural ligands 
were unidentified at the time of their discovery (3). The first 
candidate natural ligand was 9-cis-retinoic acid (9-cis-RA), 
but many researchers were not capable to identify endogenous 
9-cis-RA in cells either in culture or in vivo without existence or 
addition of its isomer all-trans retinoic acid (ATRA) (3). Other 
RXR ligands are polyunsaturated fatty acids, such as docosahex-
aenoic acid (22:6), arachidonic acid (20:4), and oleic acid (18:1), 
and a saturated metabolite of chlorophyll, phytanic acid. In the 
nucleus, RXR works as a transcription factor and binds as a 
homodimer or heterodimer (bound to a different nuclear recep-
tor) to definite 6 bp sequences of DNA in the promoter regions 
of specific genes (3). The promoter site [response element (RE)] 
composed of two 6  bp sequences (half-sites) separated by a 
discrete number of bases to which the RXR–nuclear receptor 
heterodimer binds [5′-PuG(G/T)TCA-(X)n-PuG(G/T)TCA-
3′] is determined through binding by the ligand of the nuclear 
receptor partner. The sequences may be reiterated directly (DR), 
inverted (IR), everted (ER), palindromic (pal), or disordered in 
relation to the dimer bound (3).
CiRCADiAn RHYTHMiCiTY AnD 
nUCLeAR ReCePTORS
The nuclear receptor superfamily encompasses 49 members, 
which manage lipid and carbohydrate metabolism and harmonize 
various features of organ physiology, as well as tissue develop-
ment and organism reproduction (4). The nuclear receptors are 
expressed differently in the various tissues (5) and particularly in 
metabolically active tissues (liver, muscle, and white and brown 
adipose tissues), some of which show tissue-specific rhythmic 
fluctuations of expression characterized by 24-h periodicity 
(circadian) (6). Intermediate metabolism is hallmarked by 
time-related changes consistent with the daily light/darkness 
alternation, and periodic circadian variations in the levels of 
nuclear receptors may prompt rhythmic oscillations of the meta-
bolic pathways (7). The interplay between rhythmic changes of 
nutrient levels and ligand binding by the nuclear receptors drives 
periodic variations in downstream transcriptional events steering 
different metabolism facets. The array of rhythms is driven by 
the biological clock and in turn the nuclear receptors feedback 
to the molecular clockwork connecting circadian and metabolic 
pathways (7).
THe BiOLOGiCAL CLOCK
The organization of about 24-h rhythmicity in organism and 
cellular physiology is handled in mammals by the circadian 
timing system, a multilevel hierarchical network comprising 
central oscillators in the suprachiasmatic nuclei (SCN) of the 
hypothalamus and self-sustaining oscillators in peripheral tis-
sues. The SCN biological clocks respond to several entraining 
factors: external, such as the photic inputs perceived by the 
retinal ganglion cells and conveyed by the retinohypothalamic 
tracts, and internal, such as temperature, hormones, and 
metabolites. The SCN neurons drive the peripheral oscillators 
by way of output pathways represented by hormones (cortisol, 
melatonin) and autonomic nervous fibers (8). At the molecular 
level, the biological clock is hardwired by transcription–trans-
lation feedback loops (TTFL) revolving one cycle in approxi-
mately 24 h and operated by circadian genes and proteins. The 
positive limb of the loop is worked by the transcription factors 
Clock and Arntl, which heterodimerize and bind to E-box 
enhancer elements in the promoters of Period (Per1–3) and 
Cryptochrome (Cry1–2) genes. These genes in turn prompt the 
negative limb of the loop encoding Per1–3 and Cry1–2 pro-
teins, which interact to form a repression complex that along 
with casein kinase Iϵ (CKIϵ) translocates back into the nucleus, 
where it hinders Clock:Arntl transcriptional activity (9, 10). 
In addition, Clock:Arntl heterodimer induces the circadian 
expression of Rev-erbα and Rora genes, which encode the 
nuclear receptors Rev-Erbα alpha and RORα respectively. In 
turn, Rev-Erbα negatively controls the rhythmic transcription 
of Arntl gene, competing with RORα at the specific REs (11). 
The circadian proteins undergo posttranslational modifica-
tions, in particular phosphorylation/dephosphorylation and 
acetylation/deacetylation cycles. Per1–3 and Cry1–2 proteins 
are substrates for at least three different enzymes operating 
phosphorylation: CKIδ and CKIϵ, AMPK, and glycogen syn-
thase kinase (GSK) 3β. In particular, phosphorylation by CKIδ/ϵ 
targets Per1–3/Cry1–2 proteins for degradation and regulates 
their nuclear translocation, AMPK targets Cry1–2 proteins, 
and GSK3β targets Arntl (12–15). Acetylation is operated by 
Clock, which has protein and histone acetyltransferase activity 
(16), and deacetylation by SIRT1, an NAD+-dependent protein, 
and histone deacetylase assuring high-magnitude circadian 
transcription of several core clock genes, including Arntl, Per2, 
and Cry1. SIRT1 offsets the acetyltransferase activity of Clock, 
binds Clock–Arntl heterodimer in a circadian manner and 
promotes the deacetylation and degradation of Per2 (17–19).
RXRs AnD THe nUCLeAR ReCePTOR 
SUPeRFAMiLY
The molecular clockwork controls the expression of numerous 
clock-controlled genes and tissue-specific output genes, so that 
about 15–20% of the transcriptome oscillates with circadian 
rhythmicity and manage the rhythmic changes of cell processes 
(metabolism, redox and oxphos balance, autophagy, cell cycle, 
DNA damage response) and tissue functions (liver and renal 
physiology, heart function, endocrine gland secretion) (20).
Among the clock-controlled genes, some encode nuclear 
receptors oscillating with circadian pattern in metabolically active 
tissues and specifically in the liver, such as RXRs, constitutive 
androstane receptor (CAR), estrogen-related receptor α, β, and γ, 
farnesoid receptor (FXR) α and β, glucocorticoid receptor, Nur-
related protein 1 (NURR1), peroxisome proliferator-activated 
receptor (PPAR) α, δ/β, and γ, retinoic acid receptor (RAR) α, 
β, and γ, small heterodimeric partner, and thyroid hormone 
receptor (TR) α (6). Among these, a particularly intriguing role is 
played by RXRs, forming heterodimers with numerous members 
of the nuclear receptor superfamily including PPARs, RARs, 
FXRs, LXRs, TRs, CAR, NURR1, and vitamin D3 receptors 
(VDRs) (3, 21–23). Indeed, RXRs unrestrainedly heterodimerize 
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with these members of the nuclear receptor superfamily, and by 
means of these interaction, RXR ligands, also called rexinoids, 
either transcriptionally stimulate per se the permissive subclass 
of heterodimers (PPAR/RXR, LXR/RXR, FXR/RXR, and CAR/
RXR) or synergize with partner ligands in the non-permissive 
subclass of heterodimers (RAR/RXR, VDR/RXR, and TR/RXR) 
(24–26). The permissive heterodimers become transcriptionally 
active in the presence of either an RXR-selective ligand (rexinoid) 
or a nuclear receptor partner ligand, and the simultaneous pres-
ence of both RXR and partner receptor ligands results in a coop-
erative, synergistic response (1). By contrast, non-permissive 
heterodimers are unresponsive to rexinoids alone, but these 
agonists superactivate transcription by synergizing with partner 
agonists (27).
The TR/RXR heterodimer is generally defined as non-
permissive, so that RXR is supposed to act as a silent partner not 
capable to bind specific ligands and full activity of the TR/RXR 
heterodimer is achieved only upon 3,3′,5-triiodo-l-thyronine 
(T3) binding and not by the RXR agonist. Anyway, studies 
performed with a sensitive derepression assay system showed 
that the RXR component can bind its ligand in  vivo in a TR/
RXR heterodimer without straight activation of the TR/RXR 
heterodimer, but with the TR dissociating from inhibitor(s)/
corepressor(s), as a minimum in a temporary or dynamic 
manner, leading to TR-mediated repression in the absence of a 
ligand and/or TR-mediated activation upon ligand binding (28). 
Besides, 9-cis-RA was proved to induce conformational changes 
within the TR/RXR complex and to act as an allosteric repressor 
of transactivation (29).
Retinoid X receptor heterodimers with PPAR, RAR, VDR, and 
TR consist of two directly repeated (DR) half-sites separated by 
one, two or five, three, and four bases (n), respectively, typically 
with RXR in the 5′-position. When the RXR heterodimer with 
RAR is bound to a DR-1 RE, RXR can lodge either to the 5′- or 
3′-position. The RXR homodimer favorably binds two 5′-(A/G)
GGTCA-3′ half-sites disjointed by one base (DR-1).
Kinases modulate the function of RXRs homo- and heter-
odimers. In particular, AMPK activators hinder FXRRE-bound 
RXR/FXR heterodimers exclusively acting on FXR hindering FXR 
coactivator recruitment to promoters of FXR-regulated genes and 
FXR transcriptional activity, whereas RXRs are not impacted (30). 
On the other hand, studies performed in cancer cells showed that 
RXRs are targeted by the CK1 family, and precisely RXR is bound 
and phosphorylated by CK1α in an agonist-dependent manner 
(31), as well as by GSK3β, with modulation of cell predisposition 
to RXR agonist-induced growth arrest and apoptosis and support 
of cell survival (32).
RXRs AnD THe BiOLOGiCAL CLOCK
A tight interplay has been evidenced between RXRs and the 
cogs of the molecular clockwork. RXRs are capable to join with 
members of the positive limb of TTFL with an interaction influ-
enced by circulating factors, and RA was found able to hinder 
clock genes transcription both in cultured muscle cells and in 
cardiovascular organs from intact animals (33) (Figure  1). 
Precisely, RXRα interacted in a ligand-dependent manner 
with the basic helix-loop-helix proteins Npas2 and Clock (the 
interaction strength boosted up to 15-fold upon specific ligand 
binding), but not with Bmal1, hindering, as a minimum in vitro, 
transcriptional activity of Clock/Npas2–Bmal1 heterodimers at 
the promoters of clock genes, and RA injection prompted small 
phase shifts of peripheral clocks in the heart and aorta (33). 
Besides, ATRA, 9-cis-RA, and 13-cis-RA were found capable to 
entrain circadian rhythmicity in cultured fibroblasts expressing 
Per2-luciferase (34), and retinoic acid signaling elicited central 
clock resetting upon light sensing (35, 36). Moreover, RXRα–
cofactor proteins interaction as well as RXR nuclear receptors 
heterodimerization and ligand-dependent transactivation by 
RXR was found to be modified and inhibited, respectively, 
by the basic helix-loop-helix proteins differentiated embryo 
chondrocyte (Dec) 1 and Dec2 (37). The expression of Dec1–2 
is driven by the biological clock, oscillates with circadian pattern 
in the mouse SCN and liver peaking in the subjective day, and 
takes part in the molecular clockwork, thereby blocking Clock/
Arntl-induced transactivation of the mouse Per1 promoter 
through direct protein–protein interactions with Arntl and/or 
competition for E-box elements (38, 39). Interestingly, experi-
ments performed in the rat showed that insulin prompts the 
transcription of the Dec1 gene via a phosphoinositide 3-kinase 
pathway, further supporting a direct link between intermediary 
metabolism and the molecular clockwork (40).
Besides, the interplay between RXRs and the biological 
clock showed up remarkably in an animal model of liver 
regeneration, represented by partial hepatectomy in RXRα-null 
compared to wild-type mouse. Hepatocyte proliferation showed 
approximately 20-h delay after partial hepatectomy in liver 
RXRα-deficient mice and numerous pathways were dwindled, 
in particular circadian cell cycle regulation. Furthermore, in 
accordance with the evidence that PPARα regulates the tran-
scription of both Arntl and Rev-erbα via PPAR-response and 
cis-regulatory elements in their promoters (41), the PPARα/
Arntl/Rev-erbα/P21 pathway was disrupted, and Cry1/Cry2 
and Wee1/Per1 expression as well as the expression and regula-
tion of cyclin D1/cyclin-dependent kinase (Cdk) 4, cyclin E1/
Cdk2, cyclin A2/Cdk2, and cyclin B1/Cdk1 were deranged in 
regenerating RXRα-null livers (42).
Accordingly, studies performed on the hippocampus speci-
mens of Holtzman rats harvested at 4-h intervals for 24 h showed 
clock-responsive canonical and non-canonical E-box elements 
and RORE sites in the regulatory regions of genes encoding RARs 
and RXRβ, as well as retinoic acid response elements (RAREs) 
and RXREs in Bmal1 and Per1 promoters (43).
Furthermore, an interplay between the PPARs/RXRα-
regulated system and the molecular clockwork was shown. 
PPARα/RXRα modulated Period and Cryptochrome genes 
transcription driven by Clock/Bmal1 heterodimers (44). In 
turn, Clock/Bmal1 heterodimers binding to consensus E-box 
elements modulated PPARs/RXRα-dependent transcription 
through peroxisome proliferator response element of target 
genes, comprising those encoding acyl-CoA oxidase (AOX), 
lipoprotein lipase, acyl-CoA synthase, cellular retinol-binding 
protein II, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) synthase (44).
FiGURe 1 | Scheme rendering the interaction between the molecular clockwork, the retinoid X receptors, and other nuclear receptors oscillating 
with circadian rhythmicity; see text for acronyms explanation. Ball-ended dashed lines indicate inhibition; arrow-ended dashed lines indicate activation; 
arrow-ended continuous lines indicate translocation; black lines indicate modification.
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RXRs AnD TRAnSCRiPTiOnAL ACTiviTY
Retinoid X receptors as homodimers or heterodimerizing with 
RARs manage the signaling pathways and genetic transcriptional 
programs dependent on retinoids, crucial for vertebrates devel-
opment and homeostasis (1, 3, 45). Non-steroid nuclear receptors 
bind to a core recognition element represented by the consensus 
sequence 5-AGGTCA-3, but RXRs and RARs minimally bind 
to this consensus site as monomers (45). Heterodimerization 
boosts their cooperative affinity and selectivity for RAREs, 
which are set up as coupled binding sites, so that RXR/RAR 
heterodimer binding to RAREs is more proficient respect to the 
homodimeric forms of RXR or RAR (1, 45). The nuclear receptor 
superfamily DBD maintains a highly conserved core sequence 
comprised of two zinc-nucleated modules and two α-helices 
folding into a single globular domain, with approximately 40% 
amino acid identity over a 67-residue region. In spite of the use of 
a highly conserved receptor DBD and a single major core bind-
ing sequence, complex DNA sites can be exploited with better 
selectivity by means of RXR forming combinatorial receptor 
heterodimers so that eventually two different ligands can co-
regulate transcription from the same gene-regulatory element 
(45). The nuclear receptors DBDs can produce the same pattern 
of DNA selectivity and dimerization as the full-length recep-
tors (3, 45), whereas the LBDs dimerization function of some 
receptors can additionally stabilize some dimeric assemblies 
but has no selective role for RE recognition (3, 45). The nuclear 
receptor superfamily members exploit the same consensus 
AGGTCA sequence, and transcriptional control selectivity is 
furthermore warranted by multiple arrangements of AGGTCA 
sites in the REs. RXR/RAR heterodimers preferentially bind to 
two AGGTCA sites set up in a direct repeat (DR) configuration 
hallmarked by inter-half-site spacings of 1–5 bp acknowledged 
as DR1–DR5, respectively (3, 45). The spacer size differentiates 
more respect to the sequence, with the maximum affinity binding 
sites for each RXR heterodimer and the discriminating binding 
of DRs based on inter-half-site spacings rated on a scale of 1–5. 
Other members of the nuclear superfamily link powerfully to 
inverted and everted repeats of core hexamer so that the usage 
of direct repeat geometry is less crucial (3, 45).
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RXR HeTeRODiMeRS
Combinatorial nuclear receptors are characterized by an amaz-
ing recognition mechanism that permits them to decipher a 
binding site geometry in addition to its sequence, with polarity 
adopted by the subunits of the bound receptor heterodimer 
representing an associated feature of any asymmetric RE. The 
RXR/RAR complex can assume diverse polarities when bound 
to its different REs, with different functions on the heterodimer 
dependent on ligand and corepressor binding. In this context, 
although the two hexameric binding sites may have the same 
sequence, the non-symmetric RXR/RAR complexes permits 
the position of every receptor to be distinguished as upstream 
or downstream (3, 45). A preceding structural analysis of the 
RXR/TR DBD complex linked to a DR4 thyroid RE permitted 
the direct configuration of the polarity related to that complex. 
The asymmetric assembly was recognized through the col-
laboration between DBD subunits, which arises exclusively 
with a 4-bp inter-half-site spacing length and RXR positioning 
upstream of TR (3, 45). The RXR/RAR heterodimer, whose RE 
repertoire is relatively small, mediates transcriptional control 
with low selectivity through DR1, DR2, and DR5 sequences 
located in REREs, whereas the RXR/TR complex is only 
restricted to DR4. A great flexibility measure of their DBDs 
in forming valid interaction surfaces with different effects on 
target gene regulation is hinted by the multiple high-affinity 
DNA-binding targets (3, 45). In vivo, RXR/RAR heterodimers 
on DR1 inhibit transcription with or without occurrence 
of specific ligands. The complex structure allows the DR1 to 
identify the polar assembly of the RXR and RAR DBDs as well 
as the aptitude of a DNA regulatory element to work as a typical 
allosteric ligand, triggering new conformations and/or interac-
tions eventually augmenting its own binding.
RXRs AnD DnA Res
DNA REs induce two different types of allosteric changes on 
nuclear receptors: (i) conformational changes ensuing within a 
DBD, such as the T-box α-helix deformation, prompting increased 
RXR binding DNA; (ii) DNA structures reshaping to facilitate 
protein–protein contacts. Effective RXR:RAR interactions induce 
a considerable improvement in their DNA affinity. The REs effec-
tively impinge on the interactions of full-length nuclear receptors 
with their ligands, corepressors, coactivators, AP-1, and other 
players that can impact gene expression (3, 45). Other factors 
are represented by protein flexibility and DNA surfaces exactly 
changing on a DNA site. The retinoid REs inter-halfsite spacing 
identifies a fixed geometry for a pair of nuclear receptors to inter-
mingle on, with one nucleotide change in the spacer inducing 
RXR and its partners to rotate ~35° around the double helix and 
be dislocated from each other by 3.4 Å. Consequently, RXR DBD 
must retain several fixed and different surfaces to put up its many 
combinatorial interactions, or utilize a small number of adaptable 
protein elements that can adjust to the rotations, displacements, 
and polarity of these binding sites with one or more receptor 
partners. Besides, the numerous RXR combinatorial complexes 
must be prearranged only when needed at particular control sites, 
to avoid wasting, considering the numerous pairwise interactions 
that RXR can form with its partners and the crucial role played 
by the DNA in the definition of the protein structures entailed for 
dimerization (3, 45).
RXRs’ MULTiMeRiZATiOn
In the absence of specific ligands RXRs expressly assemble as 
tetramers, which disengage when a ligand is bound, causing 
dimerization surface changes and development of RXR homodi-
mers or heterodimers if adequate partners are present. In particu-
lar, ligand binding triggers conformational changes that modify 
receptor multimerization capability and changes RXRs’ homo-/
heterodimerization as well as cofactor-binding surface (mostly 
related to helices 10/11 and 12 reshuffle) inducing a ligand 
prompted shift to act as an activator and not as a repressor of gene 
transcription (46). Other than as receptor dimers, RXRs can also 
bind to DNA as larger protein complexes (trimers, tetramers, and 
pentamers) assembling supportively on REs containing appropri-
ately repeated half-sites and crucially guaranteeing unambiguous 
DNA recognition. In particular, RXR tetramers display important 
functional plasticity and gather on REs hallmarked by varied 
half-site alignments and arrangements. The capability of RXRs 
to create tetramers and correlated oligomers seems to add to the 
synergistic transcriptional activation observed when multiple, 
spatially separated REs locate into a single promoter. RXRs 
oligomer formation contributes to isoform-specific promoter uti-
lization and allows recognition of DNA sequences not recognized 
by receptor dimers (47).
RXRs AnD THe BiOLOGiCAL CLOCK 
in LiveR MeTABOLiSM
The hepatic metabolic pathways managing glycolysis/gluconeo-
genesis, lipogenesis/fatty acid oxidation, and protein biosynthesis 
are essential for glucose, lipid, and amino acid homeostasis. 
These divergent metabolic processes require temporal separa-
tion warranted by the biological clock, which drives rhythmic 
fluctuations of liver transcripts encoding rate-limiting enzymes 
and regulators of major metabolic processes, so that metabolic 
diseases ensue when the ordered sequence of activation of the 
numerous metabolic pathways is deranged (48, 49). A huge 
number of hepatic metabolites changes with 24-h periodicity 
and, for example, the circadian regulation of hepatic function 
sets up the alternation of glycolysis and gluconeogenesis, with 
the highest levels of the former in the morning and the lowest 
levels of the latter in the evening in nocturnal respect to diurnal 
species. Among the factors which RXRs are capable to interact 
with, Clock plays a key role in the molecular clockwork and liver 
metabolism as well, as evidenced by metabolic phenotyping stud-
ies performed on mice bearing a dominant negative mutation in 
the Clock gene (ClockΔ19 mice), which show hyperlipidemia, 
hyperglycemia, and hepatic steatosis (50). Other important RXRs 
heterodimerization partners involved in liver metabolism are the 
PPAR family members, which show 24-h oscillations in mouse 
liver (6). PPARα, the prevailing hepatic isoform, stimulates fatty 
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acid catabolism by peroxisomal β-oxidation and mitochrondrial 
β- and O-oxidation in liver (3) and peaks in the early evening, 
oscillating in phase with the PGC-1α (51) and lipin 1, which 
magnifies the PPARα/PGC-1α module effects, upholding fatty 
acids utilization in early nocturnal feeding phase of rodents and 
anticipating hepatocyte capability to increase energy support for 
physical activity needs (52). Besides, PPARγ plays an important 
role in regulating glucose metabolism and fatty acid homeostasis: 
its functional activity depends on the establishment of RXR/
PPARγ heterodimers, which can be activated not only by PPARγ 
agonists, such as anti-hyperglycemic and anti-diabetic thiazo-
lidinediones, but also by RXR modulators, in particular partial 
agonists and even antagonists more than full agonists, which 
cause severe side effects (53).
Other important RXR partners are two nuclear receptors 
managing the transcription of genes enriching signaling pathways 
that regulate intestinal and hepatic lipid homeostasis: the LXRs, 
which control whole-body cholesterol, fatty acid, and glucose 
homeostasis, and the FXRs, which bind bile acids and are entailed 
in feedback inhibition of bile acid synthesis and cholesterol 
catabolism (54). RXR/LXR heterodimers manage cholesterol 
homeostasis controlling cholesterol transport and catabolism 
and triacyl glycerol synthesis gene regulation triggering ATP-
binding cassette transporters (such as ABCA1) for cholesterol 
and phospholipids efflux from intracellular receptor stores to 
extracellular acceptors, sterol responsive element binding protein 
1c, a transcription factor controlling fatty acid synthesis, apolipo-
proteins ApoD and ApoE, lipoprotein-modifying enzymes such 
as cholesterol ester (CETP), and phospholipid transfer proteins 
(3). Rexinoid agonists binding to RXR/FXR heterodimers act 
as antagonists to reduce DNA binding and coactivator recruit-
ment (3). In its side, NURR1 prompts fatty acid-binding protein 
5 via its promoter NBRE independent of RXR, whereas CAR is 
involved in response to endobiotic or xenobiotic challenge with 
induction of P450 enzymes (3).
RXRs AnD THeRAPeUTiC POTenTiAL
The reciprocal modulation deriving from the interplay between 
the ticking of biological clocks and the circadian fluctuations of 
nutrients and metabolites in the extracellular as well as intra-
cellular milieu highlighted at present by animal experiments 
suggests a critical role played by nutrient sensors and RXRs 
as well as other rhythmically oscillating nuclear receptors in 
body physiology as well as in pathophysiological mechanisms 
of disease (55). In particular, RXR agonists (e.g., bexarotene) 
impact target genes of numerous permissive partners hinting 
that these molecules may pharmacologically influence numer-
ous metabolically important pathways in vivo (56). Accordingly, 
RXR liver-specific deletion in mice provokes changes in all 
metabolic pathways regulated by RXR heterodimers, suggesting 
RXRs are essential and pleiotropic actors (57). Anyway, even if 
RXR agonists’ multipotentiality hints therapeutic significance 
on several important signaling pathways and provides boosted 
effectiveness by permissive heterodimers panactivation, poor 
selectivity represents an important drawback. Furthermore, 
considering that RXR agonists trigger hypertriglyceridemia 
and hypothyroidism in animals and humans, more appropriate 
therapeutically valuable targets could be represented by RXRs’ 
heterodimeric partners (58).
COnCLUSiOn
Various ligands ranging from cholesterol to fatty acids and fat-
soluble vitamins bind to RXR heterodimers and the cell and 
context-dependent interaction of the ligand–receptor complexes 
with co-regulators induces modulation of gene networks, which 
impact transcriptional and posttranscriptional regulatory factors 
managing intermediary metabolism and involved in metabolic 
disorders pathophysiology when deranged. RXR modulators 
function as agonists, partial agonists, and inverse agonists or 
antagonists depending on the structure of the ligand–receptor 
complex, and heterodimer-selective rexinoids could repre-
sent future valuable therapeutic tools for metabolic diseases. 
Accordingly, RXR heterodimers and their interplay with the 
biological clock are crucial in the time-related regulation of 
metabolic pathways and represent future druggable targets.
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